Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

Ethical questions about when and how to use these powerful tools will also need careful thought. The first human applications of gene therapy before birth are expected within the next decade ...

In this case, they used an innovative therapy designed to "quiet" the faulty gene, aiming to reduce the ... raising hope and new ethical questions. As we stand at the frontier of precision ...

Genetic disease is believed to be linked to 41 percent of U.S. infants' deaths, while more than 2 million children have a genetic condition.

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases ...

Giving consent for a child to receive experimental gene therapy when data is limited and risks profound is an act of great love and immense courage.

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

In a ground-breaking first for South Africa and the African continent, local patients are participating in a pioneering international gene-editing clinical trial that may revolutionise treatment for ...

The gene synthesis market has become a pivotal component of modern biotechnology, enabling rapid advancements in genomics, synthetic biology, and personalized medicine. This market is characterized by ...